DK590586D0 - 5-amino- og 5-hydroxy-6,8-difluorquinoloner og salte deraf og farmaceutiske kompositioner indeholdende forbindelserne - Google Patents

5-amino- og 5-hydroxy-6,8-difluorquinoloner og salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Info

Publication number
DK590586D0
DK590586D0 DK590586A DK590586A DK590586D0 DK 590586 D0 DK590586 D0 DK 590586D0 DK 590586 A DK590586 A DK 590586A DK 590586 A DK590586 A DK 590586A DK 590586 D0 DK590586 D0 DK 590586D0
Authority
DK
Denmark
Prior art keywords
difluoroquinolons
hydroxy
salts
amino
compounds
Prior art date
Application number
DK590586A
Other languages
English (en)
Other versions
DK590586A (da
DK166493B1 (da
Inventor
Ashok K Trehan
Joseph P Sanchez
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/808,122 external-priority patent/US4668680A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK590586D0 publication Critical patent/DK590586D0/da
Publication of DK590586A publication Critical patent/DK590586A/da
Application granted granted Critical
Publication of DK166493B1 publication Critical patent/DK166493B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK590586A 1985-12-12 1986-12-09 5-amino-, 5-alkoxy- og 5-hydroxy-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyrederivater og farmaceutisk acceptable syreadditions- og basesalte deraf og farmaceutiske kompositioner indeholdende forbindelserne DK166493B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80812285 1985-12-12
US06/808,122 US4668680A (en) 1985-12-12 1985-12-12 5-amino-6,8-difluoroquinolones as antibacterial agents
US91856886 1986-10-20
US06/918,568 US4977154A (en) 1985-12-12 1986-10-20 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents

Publications (3)

Publication Number Publication Date
DK590586D0 true DK590586D0 (da) 1986-12-09
DK590586A DK590586A (da) 1987-06-13
DK166493B1 DK166493B1 (da) 1993-06-01

Family

ID=27123084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK590586A DK166493B1 (da) 1985-12-12 1986-12-09 5-amino-, 5-alkoxy- og 5-hydroxy-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyrederivater og farmaceutisk acceptable syreadditions- og basesalte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Country Status (16)

Country Link
US (1) US4977154A (da)
EP (1) EP0226961B1 (da)
KR (1) KR900000555B1 (da)
CN (1) CN1013114B (da)
AU (1) AU591732B2 (da)
DE (1) DE3679793D1 (da)
DK (1) DK166493B1 (da)
ES (1) ES2039198T3 (da)
FI (1) FI865004A (da)
GR (1) GR3002129T3 (da)
HU (1) HU203231B (da)
IE (1) IE59261B1 (da)
IL (1) IL80933A (da)
NO (1) NO865013L (da)
OA (1) OA08561A (da)
PT (1) PT83909B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4933335A (en) * 1987-08-07 1990-06-12 Warner-Lambert Company Quinolones as antibacterial agents
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
EP0339406A1 (en) * 1988-04-19 1989-11-02 Hokuriku Pharmaceutical Co.,Ltd Quinoline-3-carboxylic acid derivatives, process for preparing the same, and composition exhibiting excellent antibacterial effect containing the same
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ATE193890T1 (de) 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
RU2140919C1 (ru) * 1994-07-18 1999-11-10 Убе Индастриз Лтд. Производные 8-трифторметилхинолинкарбоновой кислоты, фармацевтическая композиция и способ ингибирования вируса иммунодефицита
US5866150A (en) * 1996-03-20 1999-02-02 Aquaculture Technology Incorporated Antibacterially active extracts from the marine algae chaetoceros and methods of use
IN186245B (da) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
ATE407121T1 (de) * 2000-02-09 2008-09-15 Daiichi Sankyo Co Ltd Gegen säurebeständige bakterien wirksame antibakterielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten
DE102004035203A1 (de) * 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
CN102202649A (zh) 2008-10-07 2011-09-28 Mpex医药有限公司 用于改进的药物动力学的氟喹诺酮气雾剂制剂
HUE050147T2 (hu) 2008-10-07 2020-11-30 Horizon Orphan Llc Tüdõgyulladás csökkentése levofloxacin belélegzése útján
PT2473170T (pt) 2009-09-04 2019-08-23 Horizon Orphan Llc Utilização de levofloxacina em aerossol para tratamento de fibrose cística
CN104557896A (zh) * 2013-10-18 2015-04-29 沈敬山 布瑞哌唑、其关键中间体及其盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0160578B1 (en) * 1984-02-17 1989-11-23 Daiichi Seiyaku Co., Ltd. 1,8-naphthyridine derivatives
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof

Also Published As

Publication number Publication date
IL80933A0 (en) 1987-03-31
EP0226961B1 (en) 1991-06-12
ES2039198T3 (es) 1993-09-16
DK590586A (da) 1987-06-13
PT83909A (en) 1987-01-01
CN86108942A (zh) 1987-11-04
EP0226961A1 (en) 1987-07-01
FI865004A (fi) 1987-06-13
PT83909B (pt) 1989-05-12
NO865013L (no) 1987-06-15
HU203231B (en) 1991-06-28
AU6587986A (en) 1987-06-18
US4977154A (en) 1990-12-11
HUT42470A (en) 1987-07-28
KR900000555B1 (ko) 1990-01-31
KR870006034A (ko) 1987-07-08
AU591732B2 (en) 1989-12-14
OA08561A (en) 1988-09-30
IE863104L (en) 1987-06-12
IL80933A (en) 1991-06-10
GR3002129T3 (en) 1992-12-30
NO865013D0 (no) 1986-12-11
DK166493B1 (da) 1993-06-01
CN1013114B (zh) 1991-07-10
FI865004A0 (fi) 1986-12-08
IE59261B1 (en) 1994-01-26
DE3679793D1 (de) 1991-07-18

Similar Documents

Publication Publication Date Title
DK590586A (da) 5-amino- og 5-hydroxy-6,8-difluorquinoloner og salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
DK364683D0 (da) Sproejte, isaer til medicinsk anvendelse
DK185685D0 (da) 1,4-dihydro-4-oxonaphthyridinderivater og salte deraf, fremgangsmaade til fremstilling heraf og antibakterielle midler indeholdende saadanne forbindelser
NO875419D0 (no) Blandinger for farmasoeytisk tape.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI842927A (fi) Nya 1,5-benzotiazepiner med foerdelaktig inverkan pao hjaertblodkaerlen, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI861338A0 (fi) Tvaettmedel innehaollande vaordmedel foer tyg.
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
FI872313A0 (fi) Farmaceutiska kompositioner.
IT1213453B (it) Composizione farmaceutica.
ES555778A0 (es) Equipo para uso odontologico.
DK133587D0 (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
FI860780A0 (fi) Ortopedisk vaest.
FI852706A0 (fi) Skiktade kirurgiska utensilier av kompoundstruktur.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
ES554829A0 (es) Procedimiento para preparar eteres 1,3-dioxano.
DK164867C (da) Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse
IT8520591A0 (it) Formulazione farmaceutica.
NO862593D0 (no) Benzoyl-triazolyleddiksyre- eller -tioeddiksyrederivater, fremstilling derav og biocide midler inneholdende derivatene.
DK17683A (da) 2,5-benzodiazocinderivater og salte deraf
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
DE68922225D1 (de) Verdichtete pulverheilmittel.
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed